Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Eurofins Eyes Mid-Single-Digit Organic Growth In 2025

Jan 30 (Reuters) - Eurofins Scientific SE  EUFI.PA :
    * EUROFINS ACHIEVES NEW RECORD LEVEL OF ANNUAL REVENUES
WHILE
DEMONSTRATING A STRONG INCREASE IN MARGINS AND CASH GENERATION
AND RETURNS TO ITS PRE-COVID PROFITABILITY AND CASH FLOW GROWTH
TRENDS
    * EUROFINS CONFIRMS ITS LONG-TERM AVERAGE ORGANIC GROWTH
OBJECTIVE
OF 6.5% P.A.
    * ADJUSTED EBITDA MARGIN OBJECTIVE FOR FY 2027 REMAINS 24%
AND
OBJECTIVE FOR SDI2 AT EBITDA3 LEVEL REMAINS ABOUT 0.5% OF
REVENUES IN FY 2027
    * FY FCFF BEFORE DISCRETIONARY INVESTMENT IN OWNED SITES
REACHING
EUR 954M
    * TARGETS TO MAINTAIN A FINANCIAL LEVERAGE IN RANGE OF
1.5-2.5X IN
MID-TERM AND INTENDS TO GRADUALLY BRING IT DOWN TOWARDS LOWER
END OF RANGE BY FY 2027
    * BOARD OF DIRECTORS INTENDS TO PROPOSE AN ANNUAL DIVIDEND
OF EUR
0.60 PER SHARE
    * OUTLOOK 2025: TARGETS MID-SINGLE-DIGIT ORGANIC GROWTH
    * OUTLOOK 2025: POTENTIAL AVERAGE REVENUES FROM ACQUISITIONS
OF
EUR 250M, CONSOLIDATED AT MID-YEAR
    * OUTLOOK 2025: ADJUSTED EBITDA MARGIN IS TO IMPROVE ABOVE
LEVEL
IN FY 2024 OF 22.3%
    * OUTLOOK 2025: FCFF BEFORE INVESTMENT IN OWNED SITES WILL
IMPROVE
OVER LEVEL IN FY 2024
    * PROGRESSION ON MARGIN AND CASH FLOW IS LIKELY TO BE
STRONGER IN
H2 2025 VERSUS H1 2025
    * OBJECTIVE FOR CASH CONVERSION IN FY 2027 REMAINS ABOVE 50%
    * IT IS OUR BASE ASSUMPTION THAT SOME END MARKETS WILL STAY
SUBDUED IN NEAR TERM

Source text:  ID:nBw5sbXvGa 
Further company coverage:  EUFI.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Eurofins Scientific SE

See all news